Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
Status:
Completed
Trial end date:
2021-11-06
Target enrollment:
Participant gender:
Summary
This is a prospective, twin-center, cohort study in patients discharged from the hospital
after major abdominal or pelvic cancer surgery for cancer. This study is designed to evaluate
the adherence to extended deep vein thrombosis prophylaxis (DVT) with the direct oral
anticoagulant apixaban on the background of historical data from the investigator's center on
low-molecular-weight heparin (LMWH) substandard adherence in the same setting.